Cerimon Pharmaceuticals, Inc.
701 Gateway Boulevard
Suite 100
South San Francisco
California
94080
United States
Tel: 650-827-4000
Fax: 650-827-4040
Website: http://www.cerimon.com/
21 articles about Cerimon Pharmaceuticals, Inc.
-
Cerimon Pharmaceuticals, Inc. Acquires European Rights to its Topical Diclofenac Sodium Patch
11/10/2009
-
Cerimon Pharmaceuticals, Inc. Initiates Phase III Clinical Studies to Evaluate Its Topical Diclofenac Sodium Patch for Mild-to-Moderate Pain
2/25/2009
-
Cerimon Pharmaceuticals, Inc. Appoints James S. Shannon, M.D., to Board of Directors
12/2/2008
-
Cerimon Pharmaceuticals, Inc. Announces Positive Results from a Phase II Clinical Study of Its Diclofenac Sodium Patch for Acute Pain
9/11/2008
-
Cerimon Pharmaceuticals, Inc. Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis
7/9/2008
-
Cerimon Pharmaceuticals, Inc. to Conduct a Proof of Concept Study for Basiliximab for Noninfectious Uveitis, a Potentially Sight-Threatening Inflammation of the Eye
3/10/2008
-
Cerimon Pharmaceuticals, Inc. Initiates Phase II/III Clinical Studies to Evaluate its Diclofenac Patch for Mild to Moderate Pain
1/16/2008
-
Cerimon Pharmaceuticals, Inc. Names Matthew J. Meyer its General Counsel and Vice President of Business Development and Licensing
1/4/2008
-
Cerimon Pharmaceuticals, Inc. to Present at the 2007 Biotechnology Industry Organization (BIO) Investor Forum
10/5/2007
-
Cerimon Pharmaceuticals, Inc. Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch
10/2/2007
-
Cerimon Pharmaceuticals, Inc. Initiates ARREST UC-1, a Global Phase 2b Study of Basiliximab in Patients with Steroid-Refractory Ulcerative Colitis
4/4/2007
-
Cerimon Pharmaceuticals, Inc. Names Daniel Levitt, M.D., Ph.D. Executive Vice President Of Research And Development
1/8/2007
-
Cerimon Pharmaceuticals, Inc. Names Ayse Kocak Vice President Of Marketing
12/5/2006
-
Cerimon Pharmaceuticals, Inc. Announces Creation Of Scientific Advisory Board
11/3/2006
-
Cerimon Pharmaceuticals, Inc. To Present At The Rodman & Renshaw 8th Annual Healthcare Conference
11/1/2006
-
Cerimon Pharmaceuticals, Inc. Names Timothy J. McBride As Senior Vice President Of Business Development
9/28/2006
-
Cerimon Pharmaceuticals, Inc. Names James Welch As Chief Financial Officer
6/6/2006
-
Cerimon Pharmaceuticals, Inc. To Present At The BioCentury Future Leaders Conference
3/26/2006
-
Cerimon Pharmaceuticals, Inc. Licenses Exclusive Worldwide Rights To Simulect(R) For The Treatment Of Inflammatory Bowel Disease
2/21/2006
-
Cerimon Pharmaceuticals, Inc. Raises $70 Million In Series A Financing
10/26/2005